deKernion J B, Ramming K P
Natl Cancer Inst Monogr. 1978 Dec(49):347-9.
The treatment of patients with hypernephroma with xenogeneic immune RNA was discussed. The toxicity from xenogeneic immune RNA therapy was minimal in patients receiving simple doses from 4 to 64 mg intracutaneously and with cumulative doses of 450 mg during a 30-month period.
讨论了用异种免疫RNA治疗肾细胞癌患者的情况。在30个月期间,接受4至64毫克皮内单次剂量以及累积剂量达450毫克的患者中,异种免疫RNA疗法的毒性极小。